Choi N C, Kanarek D J, Grillo H C
Department of Radiation Medicine and Radiation Therapy, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
Int J Radiat Oncol Biol Phys. 1990 Jan;18(1):95-9. doi: 10.1016/0360-3016(90)90272-l.
To assess the pulmonary tolerance to postoperative radiotherapy (RT) in patients with resected lung carcinoma, a prospective study was begun in January 1977, which consisted of (a) initial pulmonary function test (PFT) and arterial blood gases (ABG) at 1 month after surgery, and before beginning of postoperative RT, and (b) follow-up PFT and ABG 1 year after postoperative RT and then every year thereafter. As of December 1987, 137 patients have been enrolled into this study, and 71 patients who were free of recurrence were subjected to the follow-up PFT and ABG. The remaining 66 patients were unable to complete the follow-up studies because of recurrent carcinoma in 60, refusal to participate in the study in 5 patients even in the absence of significant respiratory symptoms, and progressive asbestos-related pleural thickening in 1 patient. The patient characteristics were as follows: Age ranged from 27 to 79 years with the median of 59 years; sex ratio was 1.4 to 1 for male to female; surgical procedures included lobectomy in 49 and pneumonectomy in 22 patients; tumor extent consisted of Stages T1-T2N1M0 in 44, T1-T2N2M0 in 9, and T3N0-N2M0 in 18 patients, respectively. Histologic types included squamous cell carcinoma in 26, adenocarcinoma in 42, small cell carcinoma in 1, and large cell carcinoma in 2 patients. Target volume for RT included the ipsilateral hilum, the mediastinum, and the thoracic inlet including both supraclavicular fossae. A total dose of 54 Gy was delivered in 1.8 Gy of daily fractions, 5 days per week over a period of 6 weeks. Contrary to expectation, there were minor changes in PFT indices in both lobectomy and pneumonectomy patients. The follow-up PFT in the lobectomy group showed small -3% to +2% changes in mean values of ventilatory indices, lung volume, and ABG. The follow-up PFT in the pneumonectomy group also showed small -9% to +13% changes in mean values of ventilatory indices, lung volume, and ABG. Sixteen patients have had more than one PFT during the follow-up period (2 years to 10 years), and there was no significant long term adverse effect of RT on PFT in this subset of patients. Lung scans assessing regional function, which were available in six patients, were not helpful in predicting changes in PFT indices as a result of postoperative RT.
为评估肺切除术后肺癌患者对术后放疗(RT)的肺耐受性,于1977年1月开展了一项前瞻性研究,该研究包括:(a)术后1个月且在开始术后放疗前进行初始肺功能测试(PFT)和动脉血气分析(ABG);(b)术后放疗1年后进行随访PFT和ABG,此后每年进行一次。截至1987年12月,137例患者纳入本研究,71例无复发的患者接受了随访PFT和ABG。其余66例患者因60例复发、5例即使无明显呼吸道症状也拒绝参与研究以及1例进行性石棉相关胸膜增厚而无法完成随访研究。患者特征如下:年龄范围为27至79岁,中位数为59岁;男女比例为1.4比1;手术方式包括49例行肺叶切除术和22例行全肺切除术;肿瘤分期分别为44例T1 - T2N1M0期、9例T1 - T2N2M0期和18例T3N0 - N2M0期。组织学类型包括26例鳞状细胞癌、42例腺癌、1例小细胞癌和2例大细胞癌。放疗靶区包括同侧肺门、纵隔以及包括双侧锁骨上窝的胸廓入口。总剂量54 Gy,以每次1.8 Gy,每周5次,共6周的方式给予。与预期相反,肺叶切除术和全肺切除术患者的PFT指标仅有轻微变化。肺叶切除组的随访PFT显示通气指标、肺容积和ABG的平均值有小幅度 - 3%至 + 2%的变化。全肺切除组的随访PFT也显示通气指标、肺容积和ABG的平均值有小幅度 - 9%至 + 13%的变化。16例患者在随访期间(2年至10年)进行了不止一次PFT,在这部分患者中,放疗对PFT没有显著的长期不良影响。6例患者可进行评估局部功能的肺部扫描,但这些扫描无助于预测术后放疗导致的PFT指标变化。